Judith Hellman, MD
My research program is focused on basic and translational research on sepsis and other forms of inflammation-driven acute organ failure ("Inflammatory Critical Illness"). Sepsis and multiple organ failure are leading causes of death in the Intensive Care Unit. These processes result from a complex inflammatory response that is initiated through the innate immune system by interactions between host cells and microbes or endogenous host factors that are released during injury or cell death. The family of Toll-like receptors (TLRs) recognize different microbial components and endogenous host factors, and are critical in initiating inflammatory responses to infection. The Hellman Group studies TLR-dependent pathways expressed by macrophages as well as non-conventional inflammatory cells, including endothelial cells, in Inflammatory Critical Illness, focusing on their roles in coagulopathy, vascular permeability, neutrophil trafficking to organs, and organ injury and failure.
Carolyn Hendrickson, MD, MPH
Effect of smoke on Acute Respiratory Distress Syndrome
Robert A. Hiatt, MD, PhD
Cancer epidemiology and studies of cancer etiology, early development, the environment and social determinants.
Lisa Kroon, PharmD
Tobacco cessation education and training of health professionals.
Susan Lee, MD
Feasibility and acceptability of e-cigarettes versus nicotine replacement therapy for smoking cessation in the perioperative period.
James Lightwood, PhD
Estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws.
Pamela Ling, MD
Tobacco industry marketing strategies targeting young adults, women, and other high risk population, and new smokeless and novel tobacco product marketing strategies with focus on how to use tobacco industry marketing strategies to improve tobacco control programs.
Ruth Malone, RN, PhD, FAAN
Tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use.
Jyothi Marbin, MD
Impact of tobacco on low income, urban children and reducing the burden of secondhand smoke on children with focus on the impact of electronic health record changes on clinical uptake of tobacco cessation interventions, as well as the use of online trainings to train physicians on smoking cessation.
Pages
Center Leadership
Stanton A. Glantz, PhD
Director, Center for Tobacco Research Control & Education
Pamela Ling, MD MPH
Fellowship Program Director
Joe Guydish, PhD
Co-Director, Helen Diller Comprehensive Cancer Center Tobacco Control Program
Research Spotlight
Heat-not-burn (HNB) products, which heat a mixture of tobacco and other compounds to temperatures below those at which combustion occurs, deliver an inhalable aerosol containing nicotine and other chemicals.